Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - SECURE POINT TECHNOLOGIES INCFinancial_Report.xls
EX-31.1 - EXHIBIT 31.1 - SECURE POINT TECHNOLOGIES INCimsc10q_ex31z1.htm
10-Q - 140331 IMSC FORM 10-Q - SECURE POINT TECHNOLOGIES INCimsc140331_10q.htm
EX-31.2 - EXHIBIT 31.2 - SECURE POINT TECHNOLOGIES INCimsc10q_ex31z2.htm
EX-32.2 - EXHIBIT 32.2 - SECURE POINT TECHNOLOGIES INCimsc10q_ex32z2.htm



Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Implant Sciences Corporation, a Massachusetts corporation (the “Company”) on Form 10-Q for the fiscal quarter ended March 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Glenn D. Bolduc, President, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Glenn D. Bolduc

 

Glenn D. Bolduc

 

President, Chief Executive Officer

Date: May 15, 2014

 


This certification accompanies each report of the Company on Form 10-Q and Form 10-K pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by us for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by §906 has been provided to us and will be retained by us and furnished to the Securities and Exchange Commission or our staff upon request.